表紙:ゲノム編集:各種技術と世界の市場
市場調査レポート
商品コード
1079539

ゲノム編集:各種技術と世界の市場

Genome Editing: Technologies and Global Markets

出版日: | 発行: BCC Research | ページ情報: 英文 137 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=135.61円
ゲノム編集:各種技術と世界の市場
出版日: 2022年05月25日
発行: BCC Research
ページ情報: 英文 137 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のゲノム編集の市場規模は、2022年の43億米ドルから、予測期間中は24.7%のCAGRで推移し、2027年には128億米ドルの規模に成長すると予測されています。

技術別で見ると、CRISPR-Cas技術の部門は2022年の31億米ドルから、予測期間中は26.3%で推移し、2027年には99億米ドルの規模に成長すると予測されています。また、TALEN技術の部門は、2022年の5億2,450万米ドルから、18.9%で推移し、2027年には12億米ドルの規模に成長すると予測されています。

当レポートでは、世界のゲノム編集の市場を調査し、市場および技術の背景、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 現在のゲノム編集技術

  • 概要
  • ゲノム編集の歴史
  • ゲノム編集技術の比較
  • CRISPR-Cas9の発見
  • CRISPR-Casシステムのコンポーネント
  • SgRNA
  • Cas9ヌクレアーゼ
  • CRISPR-Casのしくみ
  • CRISPR-Cas9システムの利点
  • CRISPRゲノム編集の人気
  • 主要な技術的問題
  • 効率
  • 特異性/オフターゲット効果
  • デリバリーシステム
  • 臨床応用のための免疫原性リスク
  • 新しいゲノム編集システム:CRISPR-Cpf1
  • ゲノム編集による疾患治療に関する研究
  • ゲノム編集の影響
  • CRISPRの未来

第4章 ゲノム編集の用途

  • 創薬・開発
  • 臨床療法
  • 非トランスジェニック育種
  • 診断
  • その他

第5章 特許・論文発表の分析

  • 特許分析
  • 論文発表の分析

第6章 市場の内訳:技術別

  • 市場概要
  • 市場シェア・予測
  • CRISPR-Cas技術
  • TALEN
  • ZFN
  • その他

第7章 市場の内訳:用途別

  • 市場概要
  • 市場シェア・予測
  • 医薬品開発
  • 植物育種
  • 診断
  • 臨床治療
  • その他

第8章 市場の内訳:エンドユーザー別

  • 市場概要
  • 市場シェア・予測
  • バイオ技術・製薬企業
  • 農業バイオ技術企業
  • 研究機関
  • その他

第9章 市場の内訳:地域別

  • 米国
  • 欧州
  • アジア太平洋
  • その他の地域

第10章 競合情勢

  • 概要
  • 成長戦略
  • ライセンシング・契約
  • 大手バイオ医薬品企業との提携
  • 社内R&Dプログラム
  • M&A
  • ベンチャーキャピタル資金調達

第11章 ゲノム編集市場に影響を与える要因

  • 市場成長推進要因
  • 市場成長抑制要因

第12章 ゲノム編集市場に対するCOVID-19の影響

第13章 企業プロファイル

  • ALDEVRON
  • ALLELE BIOTECHNOLOGY
  • AMERICAN TYPE CULTURE COLLECTION(ATCC)
  • APPLIED STEMCELL INC.
  • ARBOR BIOTECHNOLOGIES INC.
  • ATUM(DNA2.0)
  • AUSTRALIAN BIORESOURCES LTD.
  • AXOL BIOSCIENCE LTD.
  • BEAM THERAPEUTICS
  • BIOCYTOGEN
  • BIO-RAD LABORATORIES INC.
  • BIOTOOLS CO. LTD.
  • BLUEBIRD BIO
  • BIO-TECHNE
  • CALYXT INC.
  • CANOPY BIOSCIENCES
  • CARIBOU BIOSCIENCES INC.
  • CRISPR THERAPEUTICS
  • EDITAS MEDICINE
  • GENECOPOEIA
  • GENEWIZ
  • GENSCRIPT
  • HERA BIOLABS
  • HORIZON DISCOVERY
  • INTELLIA THERAPEUTICS INC.
  • INTEGRATED DNA TECHNOLOGIES
  • JUNO THERAPEUTICS
  • LONZA
  • MAMMOTH BIOSCIENCES
  • MERCK KGAA(SIGMA-ALDRICH)
  • ORIGENE TECHNOLOGIES
  • PRECISION BIOSCIENCES INC.
  • RECOMBINETICS
  • REGENERON PHARMACEUTALS INC.
  • SANGAMO BIOSCIENCES
  • SYNTHEGO
  • SYSTEM BIOSCIENCES
  • TAKARA BIO USA INC.
  • THERMO FISHER SCIENTIFIC INC.
  • TOOLGEN INC.
  • VERTEX PHARMACEUTICALS INC.
図表

List of Tables

  • Summary Table : Global Market for Genome Editing, by Technology Type, Through 2027
  • Table 1 : Comparison of Genome Editing Technologies
  • Table 2 : Global Market for Genome Editing, by Technology Type, Through 2027
  • Table 3 : Global Market for CRISPR-Cas, by Region, Through 2027
  • Table 4 : Global Market for TALEN, by Region, Through 2027
  • Table 5 : Global Market for ZFN, by Region, Through 2027
  • Table 6 : Global Market for Other Genome-Editing Technologies, by Region, Through 2027
  • Table 7 : Global Market for Genome Editing, by Application, Through 2027
  • Table 8 : Global Market for Genome Editing in Drug Development, by Region, Through 2027
  • Table 9 : Global Market for Genome Editing for Plant Breeding, by Region, Through 2027
  • Table 10 : Global Market for Genome Editing in Diagnostics, by Region, Through 2027
  • Table 11 : Global Market for Genome Editing in Clinical Therapy, by Region, Through 2027
  • Table 12 : Global Market for Genome Editing in Other Applications, by Region, Through 2027
  • Table 13 : Global Market for Genome Editing, by End User, Through 2027
  • Table 14 : Global Market for Genome Editing for Biotechnology and Pharmaceutical Companies, by Region, Through 2027
  • Table 15 : Global Market for Genome Editing for Agricultural Biotechnology Companies, by Region, Through 2027
  • Table 16 : Companies Licensing Genome Editing Technologies from Research Institutions
  • Table 17 : Global Market for Genome Editing for Research Institutions, by Region, Through 2027
  • Table 18 : Global Market for Genome Editing for Other End Users, by Region, Through 2027
  • Table 19 : Global Market for Genome Editing, by Region, Through 2027
  • Table 20 : European Market for Genome Editing, by Country, Through 2027
  • Table 21 : Asia-Pacific Market for Genome Editing, by Country, Through 2027
  • Table 22 : Arbor Biotechnologies Inc.: Recent Developments
  • Table 23 : Bio-Rad Laboratories Inc.: Recent Developments
  • Table 24 : Bluebird Bio Inc.: Product Portfolio
  • Table 25 : Calyxt Inc.: Key Developments
  • Table 26 : Caribou Biosciences Inc.: Key Developments
  • Table 27 : CRISPR Therapeutics: Recent Developments
  • Table 28 : Horizon Company Ltd.: Key Developments
  • Table 29 : Intellia Therapeutics: Key Developments
  • Table 30 : Mammoth Biosciences: Key Developments
  • Table 31 : Precision Biosciences Inc.: Key Developments
  • Table 32 : Sangamo Biosciences: Key Developments
  • Table 33 : Thermo Fisher Scientific Inc.: Key Developments
  • Table 34 : Vertex Pharmaceuticals Inc.: Key Developments

List of Figures

  • Summary Figure : Global Market for Genome Editing, by Technology Type, 2020-2027
  • Figure 1 : Applications of Genome Editing
  • Figure 2 : Genome-Editing Patent Applications, by Major Universities at WIPO, 2018-2021
  • Figure 3 : Genome Editing Publications Shares, by Technology Type, 2021
  • Figure 4 : CRISPR Publications, by Year, 2018-2021
  • Figure 5 : ZFN Publications, by Year, 2018-2021
  • Figure 6 : TALENS Publications, by Year, 2018-2021
  • Figure 7 : Global Market Shares of Genome Editing, by Technology Type, 2021
  • Figure 8 : Global Market for CRISPR-Cas, 2020-2027
  • Figure 9 : Global Market for TALEN, 2020-2027
  • Figure 10 : Global Market for ZFN, 2020-2027
  • Figure 11 : Global Market for Other Genome-Editing Technologies, 2020-2027
  • Figure 12 : Global Market Shares of Genome Editing, by Application, 2021
  • Figure 13 : Global Market for Genome Editing in Drug Development, 2020-2027
  • Figure 14 : Global Market for Genome Editing for Plant Breeding, 2020-2027
  • Figure 15 : Global Genome-Editing Market in Diagnostics, 2020-2027
  • Figure 16 : Global Market for Genome Editing in Clinical Therapy, 2020-2027
  • Figure 17 : Global Market for Genome Editing in Other Applications, 2020-2027
  • Figure 18 : Global Market Shares of Genome Editing, by End User, 2021
  • Figure 19 : Global Market for Genome Editing for Biotechnology and Pharmaceutical Companies, 2020-2027
  • Figure 20 : Global Market for Genome Editing for Agricultural Biotechnology Companies, 2020-2027
  • Figure 21 : Global Market for Genome Editing for Research Institutions, 2020-2027
  • Figure 22 : Global Market for Genome Editing for Other End Users, 2020-2027
  • Figure 23 : Global Market Shares of Genome Editing, by Region, 2021
  • Figure 24 : U.S. Market for Genome Editing, 2020-2027
  • Figure 25 : European Market Shares of Genome Editing, by Country, 2021
  • Figure 26 : German Market for Genome Editing, 2020-2027
  • Figure 27 : U.K. Market for Genome Editing, 2020-2027
  • Figure 28 : French Market for Genome Editing, 2020-2027
  • Figure 29 : Rest of European Market for Genome Editing, 2020-2027
  • Figure 30 : Asia-Pacific Market Shares of Genome Editing, by Country, 2021
  • Figure 31 : Chinese Market for Genome Editing, 2020-2027
  • Figure 32 : Australian Market for Genome Editing, 2020-2027
  • Figure 33 : Japanese Market for Genome Editing, 2020-2027
  • Figure 34 : Rest of Asia-Pacific Market for Genome Editing, 2020-2027
  • Figure 35 : RoW Market for Genome Editing, 2020-2027
  • Figure 36 : Bio-Rad Laboratories Inc.: Annual Revenue, 2018-2020
  • Figure 37 : Bio-Rad Laboratories Inc.: Market Share, by Business Segment, 2020
  • Figure 38 : Bio-Rad Laboratories Inc.: Revenue Share, by Region, 2020
  • Figure 39 : Caribou Biosciences Inc.: Annual Revenue, 2019-2021
  • Figure 40 : Editas Medicine: Annual Revenue, 2020 and 2021
  • Figure 41 : Horizon Discovery Ltd., Annual Revenue, 2018 and 2019
  • Figure 42 : Intellia Therapeutics: Annual Revenue, 2020 and 2021
  • Figure 43 : Sangamo Biosciences: Annual Revenue, 2019-2021
  • Figure 44 : Thermo Fisher Scientific Inc.: Annual Revenue, 2019-2021
  • Figure 45 : Thermo Fisher Scientific Inc.: Market Share, by Region, 2021
  • Figure 46 : Thermo Fisher Scientific Inc.: Market Share, by Business Segments, 2021
  • Figure 47 : Thermo Fisher Scientific Inc.: Market Share, by Products, 2021
  • Figure 48 : Vertex Pharmaceuticals Inc.: Annual Revenue, 2020 and 2021
  • Figure 49 : Vertex Pharmaceuticals Inc.: Market Share, by Region, 2020
目次
Product Code: BIO146C

Highlights:

The global genome editing market should reach $12.8 billion by 2027 from $4.3 billion in 2022 at a compound annual growth rate (CAGR) of 24.7% for the forecast period of 2022 to 2027.

The CRISPR-Cas technology segment of the global genome editing market is expected to grow from $3.1 billion in 2022 to $9.9 billion in 2027 at a CAGR of 26.3% for the forecast period of 2022 to 2027.

The TALEN technology segment of the global genome editing market is expected to grow from $524.5 million in 2022 to $1.2 billion in 2027 at a CAGR of 18.9% for the forecast period of 2022 to 2027.

Report Scope:

This study is focused on the market side of genome editing and provides a comprehensive review of genome-editing technologies, along with updates on the latest related progress in the field. Different market segments for this specific market are covered. For example, application-based market segments include drug development, plant breeding, diagnostics, clinical therapy and other applications; and regional market segments include the U.S., Europe, Asia-Pacific and the Rest of the World.

Specifically centered on the market itself and its environment, this report covers almost all aspects of the global genome-editing industry, including its technologies, applications and markets, which are further segmented and analyzed by region, application, end user and technology. The report forecasts the sizes and trends of the global market as well as each of its segments. It details recent technical breakthroughs as well as major technical issues to overcome before genome editing is applied to clinical applications. The growth-driving factors and the factors that may limit the market's growth are identified. The ethical issues, regulatory issues and intellectual property rights issues are discussed. The trends of patent publications and research publications in the genome-editing area are analyzed. The competitive landscape, including various growth strategies and opportunities, is discussed. Comprehensive company profiles of the major players in the current genome-editing field are also included in this report. The report also includes impact of the COVID-19 pandemic on this market. For market estimates, data has been provided for the 2020 as the historic year, 2021 as the base year, and forecast for 2027.

Report Includes:

  • 35 tables
  • An up-to-date review of the global market for genome editing technologies and applications
  • Analyses of the global market trends, with historic market revenue (sales data) for 2020 and 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Evaluation and forecast the market size for genome editing industry, and corresponding market share analysis by technology, application, end user and geographic region
  • In-depth information (facts and figures) concerning market drivers, market deterrents and other macroeconomic forces influencing the progress of this genome editing market
  • A look at the recent technical breakthrough on the use of clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9, and how it has fuelled the rapid growth of the genome editing industry
  • Identification of companies best positioned to meet this demand owing to their proprietary technologies, mergers and acquisitions, joint ventures and other strategic alliances
  • Emphasis on the recent breakthrough innovations, key technological issues, market regulations, and current status on the intellectual property rights of the CRISPR-Cas9 genome editing technology
  • Review of patent trends and research publications for innovations within the global genome editing industry
  • Insight into recent industry structure, current competitive scenario, R&D activities, growth strategies and COVID-19 implications on the genome editing market
  • Descriptive company profiles of the leading global players, including Arbor Biotechnologies Inc., Bio-Rad Laboratories Inc., CRISPR Therapeutics, Intellia Therapeutics, Mammoth Biosciences and Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • What's New in This Update?
  • Scope of Report
  • Intended Audience
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

  • Highlights of the Market for Genome Editing

Chapter 3 Current Genome-Editing Technologies

  • Overview
  • History of Genome Editing
  • Comparison of Genome Editing Technologies
  • Discovery of CRISPR-Cas9
  • Components of CRISPR-Cas Systems
  • SgRNA
  • Cas9 Nucleases
  • How CRISPR-Cas Works
  • Advantage of the CRISPR-Cas9 System
  • Popularity of CRISPR Genome Editing
  • Major Technological Issues
  • Efficiency
  • Specificity/Off-Target Effect
  • Delivery Systems
  • Immunogenicity Risk for Clinical Applications
  • A New Genome-Editing System: CRISPR-Cpf1
  • Studies on Treating Diseases Using Genome Editing
  • Impact of Genome Editing
  • Future of CRISPR

Chapter 4 Applications of Genome Editing

  • Introduction
  • Drug Discovery and Development
  • Clinical Therapy
  • Non-transgenic Breeding
  • Diagnostics
  • Other Applications

Chapter 5 Patents and Publication Analysis

  • Patent Analysis
  • Publication Analysis

Chapter 6 Market Breakdown by Technology

  • Market Overview
  • Market Share and Forecast
  • CRISPR-Cas Technology
  • TALEN
  • ZFN
  • Other Technologies

Chapter 7 Market Breakdown by Application

  • Market Overview
  • Market Share and Forecast
  • Drug Development
  • Plant Breeding
  • Diagnostics
  • Clinical Therapy
  • Others

Chapter 8 Market Breakdown by End User

  • Market Overview
  • Market Share and Forecast
  • Biotechnology and Pharmaceutical Companies
  • Agricultural Biotechnology Companies
  • Research Institutions
  • Others

Chapter 9 Market Breakdown by Region

  • Global Market for Genome Editing by Region
  • United States
  • Europe
  • Germany
  • United Kingdom
  • France
  • Rest of Europe
  • Asia-Pacific
  • China
  • Australia
  • Japan
  • Rest of Asia-Pacific
  • Rest of the World

Chapter 10 Competitive Landscape

  • Overview
  • Growth Strategies
  • Licensing and Agreements
  • Collaborations with Big Biopharmaceutical Companies
  • In-House R&D Program
  • Mergers and Acquisitions
  • Venture Capital Funding

Chapter 11 Factors Influencing the Genome Editing Market

  • Driving Forces
  • New Genome-Editing Technologies and Applications
  • Need for Precision Medicine
  • Increasing Applications in Synthetic Biology and Drug Discovery
  • Investments from Both Public and Private Sectors
  • High Prevalence of Genetic Disorders
  • Applications in Plant and Livestock Breeding
  • Factors Limiting Market Growth
  • Stringent Regulatory Frameworks and Time-Consuming Approval Processes
  • Patent Disputes
  • Governmental Policies and Regulations
  • Regulatory Uncertainty on Genome-Edited Crops
  • Ethical Issues

Chapter 12 Impact of COVID-19 on the Genome Editing Market

  • Introduction

Chapter 13 Company Profiles

  • ALDEVRON
  • ALLELE BIOTECHNOLOGY
  • AMERICAN TYPE CULTURE COLLECTION (ATCC)
  • APPLIED STEMCELL INC.
  • ARBOR BIOTECHNOLOGIES INC.
  • ATUM (DNA2.0)
  • AUSTRALIAN BIORESOURCES LTD.
  • AXOL BIOSCIENCE LTD.
  • BEAM THERAPEUTICS
  • BIOCYTOGEN
  • BIO-RAD LABORATORIES INC.
  • BIOTOOLS CO. LTD.
  • BLUEBIRD BIO
  • BIO-TECHNE
  • CALYXT INC.
  • CANOPY BIOSCIENCES
  • CARIBOU BIOSCIENCES INC.
  • CRISPR THERAPEUTICS
  • EDITAS MEDICINE
  • GENECOPOEIA
  • GENEWIZ
  • GENSCRIPT
  • HERA BIOLABS
  • HORIZON DISCOVERY
  • INTELLIA THERAPEUTICS INC.
  • INTEGRATED DNA TECHNOLOGIES
  • JUNO THERAPEUTICS
  • LONZA
  • MAMMOTH BIOSCIENCES
  • MERCK KGAA (SIGMA-ALDRICH)
  • ORIGENE TECHNOLOGIES
  • PRECISION BIOSCIENCES INC.
  • RECOMBINETICS
  • REGENERON PHARMACEUTALS INC.
  • SANGAMO BIOSCIENCES
  • SYNTHEGO
  • SYSTEM BIOSCIENCES
  • TAKARA BIO USA INC.
  • THERMO FISHER SCIENTIFIC INC.
  • TOOLGEN INC.
  • VERTEX PHARMACEUTICALS INC.